5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates

The first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to report their earnings results. The sector mainly comprises pharma/biotech and medical device companies. Most pharma bigwigs have already reported their first-quarter earnings results. Among the large caps, J&J Merck, Bristol Myers, Novartis and Amgen have beaten both their first-quarter earnings and sales estimates, while Pfizer, Eli Lilly, Sanofi and Biogen reported mixed first-quart ...